Home › Compare › ATPGQ vs ABBV
ATPGQ yields 1000000.00% · ABBV yields 3.06%● Live data
📍 ATPGQ pulled ahead of the other in Year 1
Combined, ATPGQ + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATPGQ + ABBV for your $10,000?
On October 12, 2021, ATP Oil & Gas Corp. went out of business as per its Chapter 7 liquidation filing under bankruptcy. ATP Oil & Gas Corp. engages in the acquisition, development, and production of oil and natural gas properties primarily in the Gulf of Mexico and the United Kingdom sector of the North Sea. The company also has interests in three deepwater licenses in the Mediterranean Sea off the coast of Israel. As of December 31, 2011, it had estimated net proved reserves of 118.9 million barrels of crude oil equivalent (MMBoe), of which approximately 75.9 MMBoe were in the Gulf of Mexico and 42.9 MMBoe were in the North Sea. The company's reserves comprised approximately 78.6 million barrels of crude oil or other liquid hydrocarbons and 241.5 billion cubic feet of natural gas. It also owned leasehold and other interests in 38 offshore blocks and 49 wells comprising 23 subsea wells in the Gulf of Mexico, as well as had interests in 13 blocks and 2 company-operated subsea wells in the North Sea. ATP Oil & Gas Corporation was founded in 1991 and is headquartered in Houston, Texas.
Full ATPGQ Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.